Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...

Medically reviewed by Archana Sharma, DO Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside ...

Laura F Newell, Rachel J Cook, Advances in acute myeloid leukemia, BMJ: British Medical Journal, Vol. 375 (04 Oct 2021 - 10 Oct 2021), pp. 1-20 ...

Dec. 24, 2020 — Results from a global trial across 148 sites in 23 countries, showing a 30 per cent improvement in survival in patients with acute myeloid leukemia (AML), significantly improving ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid ...

MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment.Sophie Paczesny, M.D., Ph.D., the principal investi ...

CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant. Nature Cancer, 2025; DOI: 10.1038/s43018-025-00934-1 ...

By targeting the JMJD1C-RUNX1 interaction, researchers hope to disrupt the transcriptional programs sustaining leukemia cells, offering a universal strategy to tackle AML's heterogeneity.